Basics India Globalization Capital, Inc. India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats. IPO Date: June 1, 2006 Sector: Industrials Industry: Trading Companies and Distributors Market Cap: $32.92M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 5.50% Avg Daily Range (30 D): $0.01 | 2.84% Avg Daily Range (90 D): $0.01 | 3.56% Institutional Daily Volume Avg Daily Volume: .79M Avg Daily Volume (30 D): .75M Avg Daily Volume (90 D): .9M Trade Size Avg Trade Size (Sh.): 346 Avg Trade Size (Sh.) (30 D): 678 Avg Trade Size (Sh.) (90 D): 646 Institutional Trades Total Inst.Trades: 84 Avg Inst. Trade: $2.02M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.15M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 473.34K     News Aug 12, 2025 @ 5:00 PM Cannabinoid Clinical Trial Pipeline Gains Momentum... Source: Delveinsight Jul 10, 2025 @ 5:00 PM Cannabinoid Agonist Clinical Trial Pipeline Appear... Source: Delveinsight Jul 6, 2023 @ 12:03 PM Why VBI Vaccines Are Trading Lower By Over 23%; He... Source: Lisa Levin Mar 20, 2023 @ 12:45 PM IGC Announces Rebranding, Changes Name to IGC Pha... Source: IGC Pharma, Inc. Feb 15, 2023 @ 12:41 AM IGC Reports Financial Results for Third Fiscal Qua... Source: INDIA GLOBALIZATION CAPITAL INC. Financials   TTM Q2 2026 Q1 2026 Basic EPS $-.07 $-.02 $-.02 Diluted EPS $-.07 $-.02 $-.02 Revenue $ 1.11M $ .19M $ .33M Gross Profit $ .51M $ .1M $ .15M Net Income / Loss $ -6.45M $ -1.82M $ -1.6M Operating Income / Loss $ -8.09M $ -2.9M $ -1.91M Cost of Revenue $ .6M $ .09M $ .17M Net Cash Flow $ -.47M $ .65M $ .02M PE Ratio     Splits Apr 19, 2013:   1:10